"We need to be very rigorous about all aspects of imaging: the way FDG-PET is acquired, its analysis, and the structure of the clinical trial in which it is imbedded.
"We need to be very rigorous about all aspects of imaging: the way FDG-PET is acquired, its analysis, and the structure of the clinical trial in which it is imbedded.
"A concern we have in the treatment community is that physicians are already making decisions based on early PET assessments when we are still not clear about the optimal timing, the interpretation, and whether changing therapy (on the basis of imaging findings) affords a benefit over continuing the prior therapy.
"It is really critical not to ask too many questions in these clinical trials. We should take it one step at a time."
-Dr. Sandra Horning, a professor of medicine (oncology) at Stanford University and president of the American Society of Clinical Oncology, speaking at the 2006 Academy of Molecular Imaging meeting in Orlando.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.